Loading
HKSEHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
HK$0.26
HK$0.00 · 0.00%
PuraPharm Corporation Limited, an investment holding entity, focuses on the research, development, manufacturing, and global distribution of concentrated Chinese medicine granules (CCMG) and various Chinese healthcare products across Hong Kong, Mainland China, and international markets. Its operations are structured into five key divisions: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers a range of over-the-counter health solutions under brand names such as PuraGold, Haveron, Oncozac, and Immuzac. Beyond product sales, PuraPharm provides a clinic management system for general Chinese medical practices and operates its own chain of Nong's Chinese medicine clinics, which deliver both traditional medical services and CCMG products. The company also oversees the cultivation and trade of raw Chinese herbs, in addition to manufacturing and selling traditional Chinese medicine decoction pieces. Complementing its product offerings, it delivers modernized Chinese medicine services and diagnostic consultations. PuraPharm distributes its goods to hospitals, healthcare institutions, medical professionals, and directly to consumers via an online store. The company currently manages 43 Nong's clinics in Hong Kong and one in Guangxi, China. Founded in 1998, its headquarters are located in Tai Po, Hong Kong.
Latest quote
HK$0.26
HK$0.00 · 0.00%
PuraPharm Corporation Limited, an investment holding entity, focuses on the research, development, manufacturing, and global distribution of concentrated Chinese medicine granules (CCMG) and various Chinese healthcare products across Hong Kong, Mainland China, and international markets. Its operations are structured into five key divisions: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers a range of over-the-counter health solutions under brand names such as PuraGold, Haveron, Oncozac, and Immuzac. Beyond product sales, PuraPharm provides a clinic management system for general Chinese medical practices and operates its own chain of Nong's Chinese medicine clinics, which deliver both traditional medical services and CCMG products. The company also oversees the cultivation and trade of raw Chinese herbs, in addition to manufacturing and selling traditional Chinese medicine decoction pieces. Complementing its product offerings, it delivers modernized Chinese medicine services and diagnostic consultations. PuraPharm distributes its goods to hospitals, healthcare institutions, medical professionals, and directly to consumers via an online store. The company currently manages 43 Nong's clinics in Hong Kong and one in Guangxi, China. Founded in 1998, its headquarters are located in Tai Po, Hong Kong.
52-week range
Current HK$0.26
PuraPharm Corporation Limited, an investment holding entity, focuses on the research, development, manufacturing, and global distribution of concentrated Chinese medicine granules (CCMG) and various Chinese healthcare products across Hong Kong, Mainland China, and international markets. Its operations are structured into five key divisions: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers a range of over-the-counter health solutions under brand names such as PuraGold, Haveron, Oncozac, and Immuzac. Beyond product sales, PuraPharm provides a clinic management system for general Chinese medical practices and operates its own chain of Nong's Chinese medicine clinics, which deliver both traditional medical services and CCMG products. The company also oversees the cultivation and trade of raw Chinese herbs, in addition to manufacturing and selling traditional Chinese medicine decoction pieces. Complementing its product offerings, it delivers modernized Chinese medicine services and diagnostic consultations. PuraPharm distributes its goods to hospitals, healthcare institutions, medical professionals, and directly to consumers via an online store. The company currently manages 43 Nong's clinics in Hong Kong and one in Guangxi, China. Founded in 1998, its headquarters are located in Tai Po, Hong Kong.
52-week range
Current HK$0.26
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (HKD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 336.11M HKD | 382.09M HKD | 406.86M HKD | 448.07M HKD | 659.59M HKD |
| Cost of goods sold | 155.96M HKD | 176.95M HKD | 190.23M HKD | 187.48M HKD | 237.74M HKD |
| Gross profit | 180.16M HKD | 205.14M HKD | 216.63M HKD | 260.59M HKD | 421.85M HKD |
| Research and development | 13.76M HKD | 11.17M HKD | 14.99M HKD | 22.32M HKD | 23.95M HKD |
| Selling, general, and administrative | 204.54M HKD | 223.39M HKD | 263.18M HKD | 325.84M HKD | 380.28M HKD |
| Operating expenses | 210.14M HKD | 234.56M HKD | 282.67M HKD | 325.09M HKD | 404.23M HKD |
| Interest income | 39K HKD | 349K HKD | 293K HKD | 475K HKD | 360K HKD |
| Interest expense | 20.72M HKD | 23.71M HKD | 27.41M HKD | 24.18M HKD | 27.03M HKD |
| Depreciation and amortization | 22.45M HKD | 35.59M HKD | 48.59M HKD | 48.66M HKD | 50.14M HKD |
| Operating income | −29.99M HKD | −29.42M HKD | −51.58M HKD | −64.5M HKD | 17.62M HKD |
| Net income | −35.22M HKD | −35.44M HKD | −106.08M HKD | −120.21M HKD | −121.88M HKD |
Company facts updated Sep 11, 2026.
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Jan 29, 2020 | 18:17 | — | — |
Effective Jan 29, 2020
18:17
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
